查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1656897

骨移植片及人工骨骼替代物:市場洞察·競爭情形·市場預測 (～2032年)

Bone Graft and Substitute - Market Insights, Competitive Landscape, and Market Forecast - 2032
出版日期: | 出版商: DelveInsight | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

骨移植和骨替代品的市場規模預計將從 2024 年的 37.8625 億美元增長到 2032 年的 59.5771 億美元，預測期內的複合年增長率為 5.88%。

骨相關疾病和損傷的盛行率不斷上升，以及牙科對骨移植的需求不斷增加，大大推動了全球骨移植和骨替代品市場的發展。隨著骨質疏鬆症和骨折等骨骼疾病變得越來越普遍，特別是在老年人口中，對​​有效的骨骼再生和修復解決方案的需求正在迅速增加。老年人口的不斷增長，導致骨質退化、骨折和關節問題等問題的發生，這進一步推動了骨移植的需求，尤其是在骨科和牙科手術中。此外，產品開發活動的增加，加上合成、同種異體移植和異種移植材料的創新，提高了骨移植的有效性和可用性。為了滿足日益增長的需求，預計在預測期內（即 2025-2032 年）將推出更先進、生物相容性更強且更具成本效益的解決方案。

基於原料，天然移植物部分將在 2024 年佔據 66.85% 的市場佔有率，佔據市場主導地位。人們認為，這是由天然移植物提供的各種益處和應用所推動的。天然骨移植通常是指從一個生物體移植到另一個生物體的活組織或骨結構，無論是在同一物種內或跨物種。這些移植物包括骨頭和軟骨等組織。

這些骨移植來自生物，這意味著它們與接受者的身體組織相容。這降低了排斥的風險並促進了與周圍組織的整合。此外，與合成材料相比，天然骨移植（例如自體骨和異體骨移植）的感染風險較低，因為它們不會將異物引入體內。一旦與接受者的骨組織結合，天然骨移植就能提供長期的強度和支撐，確保治療部位的健康。

按地區劃分，北美將在 2024 年佔據最大佔有率，為 47.92%，預計在 2025 年至 2032 年的預測期內複合年增長率為 5.54%。這是由於脊椎相關疾病發生率不斷上升、牙齒脫落病例不斷增加、骨科手術增加、新產品推出以及對研發的重視程度不斷提高等因素造成的。

本報告提供全球骨移植片及人工骨骼替代物的市場調查，彙整市場概要，市場影響因素及市場機會分析，法律制度，市場規模的轉變·預測，各種區分·地區/各主要國家的詳細分析，競爭情形，主要企業簡介等資訊。

目錄

第1章 骨移植片及人工骨骼替代物市場報告:簡介

  • 調查範圍
  • 市場區隔
  • 市場前提條件

第2章 骨移植片及人工骨骼替代物市場:摘要整理

  • 市場概要

第3章 競爭情形

第4章 法規分析

  • 美國
  • 歐洲
  • 日本
  • 中國

第5章 骨移植片及人工骨骼替代物市場:主要要素分析

  • 推動市場要素
    • 骨相關疾病與創傷病例增加
    • 牙科對骨移植的需求不斷增加
    • 老年人口不斷增加
    • 增加全球產品開發活動
  • 市場限制與課題
    • 大面積骨缺損治療的局限性
    • 與自體和異體移植相關的風險
  • 市場機會
    • 合成和天然多孔骨替代品的開發

第6章 骨移植片及人工骨骼替代物市場:波特的五力分析

第7章 骨移植片及人工骨骼替代物市場評估

  • 各原料
    • 自然地
    • 合成
  • 各產品類型
    • 同類移植
    • 異種移植
    • 其他
  • 各用途
    • 顱顎顏面
    • 牙科
    • 關節重建
    • 脊椎融合
  • 各終端用戶
    • 醫院·診所
    • 專門診所
  • 各地區
    • 北美
    • 歐洲
    • 亞太地區
    • 其他地區

第8章 骨移植片及人工骨骼替代物市場:企業·產品簡介

  • Medtronic plc.
  • Johnson & Johnson
  • Smith & Nephew
  • Stryker
  • Dentsply Sirona Inc.
  • Globus Medical Inc.
  • Baxter
  • Arthrex, Inc.
  • OssDsign
  • Orthofix Medical Inc.
  • Xtant Medical Holdings, Inc.
  • Halma
  • B. Braun Melsungen AG
  • Exactech Inc. Zimmer Biomet Institute Straumann AG
  • Southern Implants
  • MedBone Biomaterials
  • Noraker
  • BioHorizons

第9章 KOL的見解

第10章 計劃的方法

第11章 關於DelveInsight

第12章 免責聲明·聯絡方式

Product Code: DIMDCL0085

Bone Graft and Substitutes Market by Source (Natural and Synthetic), Product Type (Allograft {DBM, BMP, and Cell-Based Matrices}, Xenograft, and Others), Application (Craniomaxillofacial, Dental, Joint Reconstruction, Spinal Fusion, and Others), End-User (Hospitals & Clinics, Specialty Clinics, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to grow at a steady CAGR forecast till 2032 owing to the increasing prevalence of bone-related disorders and trauma cases, rising demand for bone grafts in dentistry, the growing geriatric population, and increase in product development activities across the globe

The bone graft and substitutes market was valued at USD 3,786.25 million in 2024, growing at a CAGR of 5.88% during the forecast period from 2025 to 2032 to reach USD 5,957.71 million by 2032. The increasing prevalence of bone-related disorders and trauma cases, coupled with a rising demand for bone grafts in dentistry, is significantly boosting the global market for bone grafts and substitutes. As bone diseases such as osteoporosis and bone fractures become more common, particularly among the aging population, the need for effective bone regeneration and repair solutions has surged. The growing geriatric population, which is more prone to bone degeneration, fractures, and joint issues, further drives demand for bone grafts, especially in orthopedic and dental procedures. Additionally, the increase in product development activities, with innovations in synthetic, allograft, and xenograft materials, is enhancing the effectiveness and availability of bone graft substitutes. These factors collectively contribute to the expansion of the bone graft and substitutes market, with more advanced, biocompatible, and cost-effective solutions being introduced to meet the rising demand during the forecast period from 2025 to 2032.

Bone Graft and Substitutes Market Dynamics:

As per the International Osteoporosis Foundation (2023), over 8.9 million fractures related to osteoporosis occur annually. Osteoporosis is one of the common degenerative bone diseases where the body starts to lose bone mass or makes too little bone. As individuals with osteoporosis are more prone to fractures, especially in areas like the hip, spine, and wrist, the demand for effective solutions to repair and regenerate damaged bone tissue rises. Bone grafts and substitutes, which are used to promote bone healing and provide structural support, are essential in treating fractures caused by osteoporosis, particularly when fractures are complex or difficult to heal thereby boosting the overall market of bone graft and substitute across the globe.

Moreover, the rising number of trauma cases has also contributed to the rising demand for bone grafts and substitutes. As per the World Health Organization factsheet (2023) on road traffic injuries, road injuries are the leading cause of fatality in children and young adults in the age group 5-29 years. The same factsheet further stated that near about 20-50 million people suffer from non-fatal injuries in road accidents resulting in a disability as a result of their injury. In road traffic accidents, the force of impact often leads to complex and severe fractures, including fractures of the limbs, pelvis, spine, and other critical areas, which require immediate and effective treatment. As these injuries often result in substantial bone loss or damage, bone grafts and substitutes become essential for repairing the damaged bones, promoting healing, and ensuring functional recovery.

Another factor contributing to the growth of the bone graft and substitutes market is the rising demand for bone grafts in the dental sector. According to the latest research study "Bone Graft and Substitutes in Dentistry: A Review of Current Trends and Developments" (2021), current estimates suggest that globally, roughly 2.2 million bone transplant surgeries are conducted each year, costing an approximate value of USD 664 million in 2021. The number of surgical procedures for treating bony abnormalities is estimated to grow by approximately 13% yearly.

Additionally, the increase in strategic activities among the key market players is further boosting the market of bone grafts and substitutes across the globe. For instance, in April 2023, ZimVie announced the launches of RegenerOss(R) CC allograft particulate and RegenerOss(R) bone graft plug for filling extraction sockets and periodontal defects.

Thus, the factors mentioned above are expected to boost the overall market of bone grafts and substitutes across the globe during the forecast period from 2025 to 2032.

However, limitations in the management of large bone defects and risks associated with autografts and allografts may hinder the future market of bone grafts and substitutes across the globe during the forecasted period.

Bone Graft and Substitutes Market Segment Analysis:

Bone Graft and Substitutes Market by Source (Natural and Synthetic), Product Type (Allograft {DBM, BMP, and Cell-Based Matrices}, Xenograft, and Others), Application (Craniomaxillofacial, Dental, Joint Reconstruction, Spinal Fusion, and Others), End-User (Hospitals & Clinics, Specialty Clinics, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

The natural category in the bone graft and substitutes market is estimated to dominate the market with a market share of 66.85% in 2024. This can be attributed to the various advantages and applications provided by grafts taken from natural sources which will be responsible for driving the demand for natural bone grafts and substitutes market during the given forecast period. Natural bone grafts typically refer to biological tissues or bone structures transplanted from one organism to another within the same species or sometimes across species. These grafts include tissues such as bones and cartilage.

These bone grafts are derived from biological sources, making them compatible with the recipient's body tissues. This further reduces the risk of rejection and promotes integration with surrounding tissues. Additionally, natural bone grafts, such as autografts (tissues taken from the patient's own body) or allografts (tissues from a donor of the same species), have a lower risk of infection compared to synthetic materials because they do not introduce foreign substances into the body. Natural bone grafts, once integrated into the recipient's bone tissue, provide long-term strength and support, ensuring the health of the treated area.

Thus, the factors mentioned above are expected to boost the segment thereby boosting the overall market of bone grafts and substitutes across the globe.

North America is expected to dominate the overall bone graft and substitutes market:

Among all regions, North America is estimated to hold the largest share of 47.92% in the global bone graft and substitutes market in 2024, growing at a CAGR of 5.54% during the forecast period from 2025 to 2032. This can be attributed to the growing prevalence of spine-related disorders, and increasing cases of tooth loss, coupled with other supportive factors such as increasing orthopedic surgical procedures, new product launches, and increased focus on research and development among other factors that are driving the overall growth of the bone graft and substitutes market over the forecast period.

As per the data provided by the United Spinal Association (2022), every year approximately 17,700 Americans acquire a spinal cord injury. Roughly 78% are men, and their average age is 43. Most spinal cord injuries happened as a result of a vehicle accident (39.3%), followed closely by falls (31.8%), trailed by violence (13.2%), sports (8%), and medical/surgery (4.3%). Conditions such as degenerative disc disease, spinal deformities, fractures, and spinal stenosis often require surgical interventions, including spinal fusion procedures, to stabilize the spine and alleviate pain. Bone grafts and substitutes are essential in these surgeries to promote bone healing, ensure proper fusion of vertebrae, and restore spinal integrity.

Additionally, as per the data provided by the Centre for Disease Control and Prevention (2024), about 1 in 10 adults (11%) aged 65 to 74 years had lost all their teeth. Tooth loss, often caused by periodontal disease, trauma, tooth decay, or aging, results in alveolar bone resorption a condition where the jawbone deteriorates due to the absence of a tooth root to stimulate bone growth. To address this, bone grafts and substitutes are commonly used to regenerate lost bone, providing a stable foundation for dental implants and restoring oral functionality and aesthetics. The rising global prevalence of tooth loss, particularly among the aging population, has created a substantial demand for bone regeneration solutions in dentistry.

Furthermore, the increasing number of product development activities in the region is further going to accelerate the growth of the spinal non-fusion devices market. For instance, in September 2024, Cerapedics Inc., a global orthopedics company focused on improving bone repair treatments, announced that the U.S. Food and Drug Administration (FDA) had approved an expanded use and labeling for its i-FACTOR P-15 Peptide Enhanced Bone Graft. With this approval, i-FACTOR was cleared for use in single-level anterior cervical discectomy fusion (ACDF) procedures. It could be used with an allograft bone ring or combined with a PEEK, titanium alloy, or PEEK/titanium fusion interbody device approved by the FDA for cervical spine use, along with supplemental anterior plate fixation.

Thus, the above-mentioned factors are expected to escalate the market of bone grafts and substitutes in the region.

Bone Graft and Substitutes Market Key Players:

Some of the key market players operating in the bone graft and substitutes market include Medtronic plc., Johnson & Johnson, Smith & Nephew, Stryker, Dentsply Sirona Inc., Globus Medical Inc., Baxter, Arthrex, Inc., OssDsign, Orthofix Medical Inc., Xtant Medical Holdings, Inc., Halma, B. Braun Melsungen AG, Exactech Inc., Zimmer Biomet, Institut Straumann AG, Southern Implants, MedBone Biomaterials, Noraker, BioHorizons, and others.

Recent Developmental Activities in the Bone Graft and Substitutes Market:

  • In September 2022, Ivory Dentin Graft, the first and only dentin graft, received CE mark approval.
  • In August 2022, Orthofix Medical and CGBio announced the strategic partnership agreement for Novosis rhBMP-2 bone graft solutions.

Key Takeaways From the Bone Graft and Substitutes Market Report Study

  • Market size analysis for current bone graft and substitutes size (2024), and market forecast for 8 years (2025 to 2032)
  • Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures happened over the last 3 years.
  • Key companies dominating the bone graft and substitutes market.
  • Various opportunities available for the other competitors in the bone graft and substitutes market space.
  • What are the top-performing segments in 2024? How these segments will perform in 2032?
  • Which are the top-performing regions and countries in the current bone graft and substitutes market scenario?
  • Which are the regions and countries where companies should have concentrated on opportunities for bone graft and substitute market growth in the coming future?

Target Audience Who Can be Benefited From This Bone Graft and Substitutes Market Report Study

  • Bone graft and substitute product providers
  • Research organizations and consulting companies
  • Bone graft and substitutes-related organizations, associations, forums, and other alliances
  • Government and corporate offices
  • Start-up companies, venture capitalists, and private equity firms
  • Distributors and traders dealing in bone grafts and substitutes
  • Various end-users who want to know more about the bone graft and substitutes market and the latest technological developments in the bone graft and substitutes market.

Frequently Asked Questions for the Bone Graft and Substitutes Market:

1. What are bone grafts and substitutes?

  • Bone grafts are surgical structures and molds used to replace or augment bone tissues that are missing or damaged. It involves taking bone from one area of the body (autograft), using bone from a donor (allograft), or utilizing synthetic materials (synthetic grafts) to promote bone healing and regeneration.

2. What is the market for bone grafts and substitutes?

  • The bone graft and substitutes market was valued at USD 3,786.25 million in 2024, growing at a CAGR of 5.88% during the forecast period from 2025 to 2032 to reach USD 5,957.71 million by 2032.

3. What are the drivers for the global bone graft and substitutes market?

  • The increasing prevalence of bone-related disorders and trauma cases, coupled with a rising demand for bone grafts in dentistry, is significantly boosting the global market for bone grafts and substitutes. As bone diseases such as osteoporosis and bone fractures become more common, particularly among the aging population, the need for effective bone regeneration and repair solutions has surged. The growing geriatric population, which is more prone to bone degeneration, fractures, and joint issues, further drives demand for bone grafts, especially in orthopedic and dental procedures. Additionally, the increase in product development activities, with innovations in synthetic, allograft, and xenograft materials, is enhancing the effectiveness and availability of bone graft substitutes. These factors collectively contribute to the expansion of the bone graft and substitutes market, with more advanced, biocompatible, and cost-effective solutions being introduced to meet the rising demand during the forecast period from 2025 to 2032.

4. Who are the key players operating in the global bone graft and substitutes market?

  • Some of the key market players operating in the bone graft and substitutes are Medtronic plc., Johnson & Johnson, Smith & Nephew, Stryker, Dentsply Sirona Inc., Globus Medical Inc., Baxter, Arthrex, Inc., OssDsign, Orthofix Medical Inc., Xtant Medical Holdings, Inc., Halma, B. Braun Melsungen AG, Exactech Inc., Zimmer Biomet, Institut Straumann AG, Southern Implants, MedBone Biomaterials, Noraker, BioHorizons, and others.

5. Which region has the highest share in the global bone graft and substitutes market?

  • North America region is anticipated to dominate the overall bone graft and substitutes market due to the growing prevalence of spine-related disorders, and increasing cases of tooth loss, coupled with other supportive factors such as increasing orthopedic surgical procedures, new product launches, and increased focus on research and development among other factors that are driving the overall growth of the bone graft and substitutes market over the forecast period.

Table of Contents

1. Bone Graft and Substitutes Market Report Introduction

  • 1.1. Scope of the Study
  • 1.2. Market Segmentation
  • 1.3. Market Assumption

2. Bone Graft and Substitutes Market Executive Summary

  • 2.1. Market at Glance

3. Competitive Landscape

4. Regulatory Analysis

  • 4.1. The United States
  • 4.2. Europe
  • 4.3. Japan
  • 4.4. China

5. Bone Graft and Substitutes Market Key Factors Analysis

  • 5.1. Bone Graft and Substitutes Market Drivers
    • 5.1.1. The increasing prevalence of bone-related disorders and trauma cases
    • 5.1.2. Rising demand for bone grafts in dentistry
    • 5.1.3. The growing geriatric population
    • 5.1.4. Increase in product development activities across the globe
  • 5.2. Bone Graft and Substitutes Market Restraints and Challenges
    • 5.2.1. Limitations in the management of large bone defects
    • 5.2.2. Risks associated with autografts and allografts
  • 5.3. Bone Graft and Substitutes Market Opportunities
    • 5.3.1. Development of Synthetic and Natural Porous Substitutes

6. Bone Graft and Substitutes Market Porter's Five Forces Analysis

  • 6.1. Bargaining Power of Suppliers
  • 6.2. Bargaining Power of Consumers
  • 6.3. Threat of New Entrants
  • 6.4. Threat of Substitutes
  • 6.5. Competitive Rivalry

7. Bone Graft and Substitutes Market Assessment

  • 7.1. By Source
    • 7.1.1. Natural
    • 7.1.2. Synthetic
  • 7.2. By Product Type
    • 7.2.1. Allograft
      • 7.2.1.1. DBM
      • 7.2.1.2. BMP
      • 7.2.1.3. Cell-Based Matrices
    • 7.2.2. Xenograft
    • 7.2.3. Others
  • 7.3. By Application
    • 7.3.1. Craniomaxillofacial
    • 7.3.2. Dental
    • 7.3.3. Joint Reconstruction
    • 7.3.4. Spinal Fusion
    • 7.3.5. Others
  • 7.4. By End-User
    • 7.4.1. Hospitals & Clinics
    • 7.4.2. Specialty Clinics
    • 7.4.3. Others
  • 7.5. By Geography
    • 7.5.1. North America
      • 7.5.1.1. United States Bone Graft and Substitutes Market Size in USD Million (2022-2032)
      • 7.5.1.2. Canada Bone Graft and Substitutes Market Size in USD Million (2022-2032)
      • 7.5.1.3. Mexico Bone Graft and Substitutes Market Size in USD Million (2022-2032)
    • 7.5.2. Europe
      • 7.5.2.1. France Bone Graft and Substitutes Market Size in USD Million (2022-2032)
      • 7.5.2.2. Germany Bone Graft and Substitutes Market Size in USD Million (2022-2032)
      • 7.5.2.3. United Kingdom Bone Graft and Substitutes Market Size in USD Million (2022-2032)
      • 7.5.2.4. Italy Bone Graft and Substitutes Market Size in USD Million (2022-2032)
      • 7.5.2.5. Spain Bone Graft and Substitutes Market Size in USD Million (2022-2032)
      • 7.5.2.6. Rest of Europe Bone Graft and Substitutes Market Size in USD Million (2022-2032)
    • 7.5.3. Asia-Pacific
      • 7.5.3.1. China Bone Graft and Substitutes Market Size in USD Million (2022-2032)
      • 7.5.3.2. Japan Bone Graft and Substitutes Market Size in USD Million (2022-2032)
      • 7.5.3.3. India Bone Graft and Substitutes Market Size in USD Million (2022-2032)
      • 7.5.3.4. Australia Bone Graft and Substitutes Market Size in USD Million (2022-2032)
      • 7.5.3.5. South Korea Bone Graft and Substitutes Market Size in USD Million (2022-2032)
      • 7.5.3.6. Rest of Asia-Pacific Bone Graft and Substitutes Market Size in USD Million (2022-2032)
    • 7.5.4. Rest of the World (RoW)
      • 7.5.4.1. Middle East Bone Graft and Substitutes Market Size in USD Million (2022-2032)
      • 7.5.4.2. Africa Bone Graft and Substitutes Market Size in USD Million (2022-2032)
      • 7.5.4.3. South America Bone Graft and Substitutes Market Size in USD Million (2022-2032)

8. Bone Graft and Substitutes Market Company and Product Profiles

  • 8.1. Medtronic plc.
    • 8.1.1. Company Overview
    • 8.1.2. Company Snapshot
    • 8.1.3. Financial Overview
    • 8.1.4. Product Listing
    • 8.1.5. Entropy
  • 8.2. Johnson & Johnson
    • 8.2.1. Company Overview
    • 8.2.2. Company Snapshot
    • 8.2.3. Financial Overview
    • 8.2.4. Product Listing
    • 8.2.5. Entropy
  • 8.3. Smith & Nephew
    • 8.3.1. Company Overview
    • 8.3.2. Company Snapshot
    • 8.3.3. Financial Overview
    • 8.3.4. Product Listing
    • 8.3.5. Entropy
  • 8.4. Stryker
    • 8.4.1. Company Overview
    • 8.4.2. Company Snapshot
    • 8.4.3. Financial Overview
    • 8.4.4. Product Listing
    • 8.4.5. Entropy
  • 8.5. Dentsply Sirona Inc.
    • 8.5.1. Company Overview
    • 8.5.2. Company Snapshot
    • 8.5.3. Financial Overview
    • 8.5.4. Product Listing
    • 8.5.5. Entropy
  • 8.6. Globus Medical Inc.
    • 8.6.1. Company Overview
    • 8.6.2. Company Snapshot
    • 8.6.3. Financial Overview
    • 8.6.4. Product Listing
    • 8.6.5. Entropy
  • 8.7. Baxter
    • 8.7.1. Company Overview
    • 8.7.2. Company Snapshot
    • 8.7.3. Financial Overview
    • 8.7.4. Product Listing
    • 8.7.5. Entropy
  • 8.8. Arthrex, Inc.
    • 8.8.1. Company Overview
    • 8.8.2. Company Snapshot
    • 8.8.3. Financial Overview
    • 8.8.4. Product Listing
    • 8.8.5. Entropy
  • 8.9. OssDsign
    • 8.9.1. Company Overview
    • 8.9.2. Company Snapshot
    • 8.9.3. Financial Overview
    • 8.9.4. Product Listing
    • 8.9.5. Entropy
  • 8.10. Orthofix Medical Inc.
    • 8.10.1. Company Overview
    • 8.10.2. Company Snapshot
    • 8.10.3. Financial Overview
    • 8.10.4. Product Listing
    • 8.10.5. Entropy
  • 8.11. Xtant Medical Holdings, Inc.
    • 8.11.1. Company Overview
    • 8.11.2. Company Snapshot
    • 8.11.3. Financial Overview
    • 8.11.4. Product Listing
    • 8.11.5. Entropy
  • 8.12. Halma
    • 8.12.1. Company Overview
    • 8.12.2. Company Snapshot
    • 8.12.3. Financial Overview
    • 8.12.4. Product Listing
    • 8.12.5. Entropy
  • 8.13. B. Braun Melsungen AG
    • 8.13.1. Company Overview
    • 8.13.2. Company Snapshot
    • 8.13.3. Financial Overview
    • 8.13.4. Product Listing
    • 8.13.5. Entropy
  • 8.14. Exactech Inc.
    • 8.14.1. Company Overview
    • 8.14.2. Company Snapshot
    • 8.14.3. Financial Overview
    • 8.14.4. Product Listing
    • 8.14.5. Entropy
  • 8.15. Zimmer Biomet
    • 8.15.1. Company Overview
    • 8.15.2. Company Snapshot
    • 8.15.3. Financial Overview
    • 8.15.4. Product Listing
    • 8.15.5. Entropy
  • 8.16. Institute Straumann AG
    • 8.16.1. Company Overview
    • 8.16.2. Company Snapshot
    • 8.16.3. Financial Overview
    • 8.16.4. Product Listing
    • 8.16.5. Entropy
  • 8.17. Southern Implants
    • 8.17.1. Company Overview
    • 8.17.2. Company Snapshot
    • 8.17.3. Financial Overview
    • 8.17.4. Product Listing
    • 8.17.5. Entropy
  • 8.18. MedBone Biomaterials
    • 8.18.1. Company Overview
    • 8.18.2. Company Snapshot
    • 8.18.3. Financial Overview
    • 8.18.4. Product Listing
    • 8.18.5. Entropy
  • 8.19. Noraker
    • 8.19.1. Company Overview
    • 8.19.2. Company Snapshot
    • 8.19.3. Financial Overview
    • 8.19.4. Product Listing
    • 8.19.5. Entropy
  • 8.20. BioHorizons
    • 8.20.1. Company Overview
    • 8.20.2. Company Snapshot
    • 8.20.3. Financial Overview
    • 8.20.4. Product Listing
    • 8.20.5. Entropy

9. KOL Views

10. Project Approach

11. About DelveInsight

12. Disclaimer & Contact Us

List of Tables

  • Table 1: Competitive Analysis
  • Table 2: Bone Graft and Substitutes Market in Global (2022-2032)
  • Table 3: Bone Graft and Substitutes Market in Global by Source (2022-2032)
  • Table 4: Bone Graft and Substitutes Market in Global by Product Type (2022-2032)
  • Table 5: Bone Graft and Substitutes Market in Global by Application (2022-2032)
  • Table 6: Bone Graft and Substitutes Market in Global by End-User (2022-2032)
  • Table 7: Bone Graft and Substitutes Market in Global by Geography (2022-2032)
  • Table 8: Bone Graft and Substitutes Market in North America (2022-2032)
  • Table 9: Bone Graft and Substitutes Market in the United States (2022-2032)
  • Table 10: Bone Graft and Substitutes Market in Canada (2022-2032)
  • Table 11: Bone Graft and Substitutes Market in Mexico (2022-2032)
  • Table 12: Bone Graft and Substitutes Market in Europe (2022-2032)
  • Table 13: Bone Graft and Substitutes Market in France (2022-2032)
  • Table 14: Bone Graft and Substitutes Market in Germany (2022-2032)
  • Table 15: Bone Graft and Substitutes Market in the United Kingdom (2022-2032)
  • Table 16: Bone Graft and Substitutes Market in Italy (2022-2032)
  • Table 17: Bone Graft and Substitutes Market in Spain (2022-2032)
  • Table 18: Bone Graft and Substitutes Market in the Rest of Europe (2022-2032)
  • Table 19: Bone Graft and Substitutes Market in Asia-Pacific (2022-2032)
  • Table 20: Bone Graft and Substitutes Market in China (2022-2032)
  • Table 21: Bone Graft and Substitutes Market in Japan (2022-2032)
  • Table 22: Bone Graft and Substitutes Market in India (2022-2032)
  • Table 23: Bone Graft and Substitutes Market in Australia (2022-2032)
  • Table 24: Bone Graft and Substitutes Market in South Korea (2022-2032)
  • Table 25: Bone Graft and Substitutes Market in Rest of Asia-Pacific (2022-2032)
  • Table 26: Bone Graft and Substitutes Market in the Rest of the World (2022-2032)
  • Table 27: Bone Graft and Substitutes Market in the Middle East (2022-2032)
  • Table 28: Bone Graft and Substitutes Market in Africa (2022-2032)
  • Table 29: Bone Graft and Substitutes Market in South America (2022-2032)

List of Figures

  • Figure 1: Competitive Analysis
  • Figure 2: Bone Graft and Substitutes Market in Global (2022-2032)
  • Figure 3: Bone Graft and Substitutes Market in Global by Source (2022-2032)
  • Figure 4: Bone Graft and Substitutes Market in Global by Product Type (2022-2032)
  • Figure 5: Bone Graft and Substitutes Market in Global by Application (2022-2032)
  • Figure 6: Bone Graft and Substitutes Market in Global by End-User (2022-2032)
  • Figure 7: Bone Graft and Substitutes Market in Global by Geography (2022-2032)
  • Figure 8: Bone Graft and Substitutes Market in North America (2022-2032)
  • Figure 9: Bone Graft and Substitutes Market in the United States (2022-2032)
  • Figure 10: Bone Graft and Substitutes Market in Canada (2022-2032)
  • Figure 11: Bone Graft and Substitutes Market in Mexico (2022-2032)
  • Figure 12: Bone Graft and Substitutes Market in Europe (2022-2032)
  • Figure 13: Bone Graft and Substitutes Market in France (2022-2032)
  • Figure 14: Bone Graft and Substitutes Market in Germany (2022-2032)
  • Figure 15: Bone Graft and Substitutes Market in the United Kingdom (2022-2032)
  • Figure 16: Bone Graft and Substitutes Market in Italy (2022-2032)
  • Figure 17: Bone Graft and Substitutes Market in Spain (2022-2032)
  • Figure 18: Bone Graft and Substitutes Market in the Rest of Europe (2022-2032)
  • Figure 19: Bone Graft and Substitutes Market in Asia-Pacific (2022-2032)
  • Figure 20: Bone Graft and Substitutes Market in China (2022-2032)
  • Figure 21: Bone Graft and Substitutes Market in Japan (2022-2032)
  • Figure 22: Bone Graft and Substitutes Market in India (2022-2032)
  • Figure 23: Bone Graft and Substitutes Market in Australia (2022-2032)
  • Figure 24: Bone Graft and Substitutes Market in South Korea (2022-2032)
  • Figure 25: Bone Graft and Substitutes Market in Rest of Asia-Pacific (2022-2032)
  • Figure 26: Bone Graft and Substitutes Market in the Rest of the World (2022-2032)
  • Figure 27: Bone Graft and Substitutes Market in the Middle East (2022-2032)
  • Figure 28: Bone Graft and Substitutes Market in Africa (2022-2032)
  • Figure 29: Bone Graft and Substitutes Market in South America (2022-2032)
  • Figure 30: Market Drivers
  • Figure 31: Market Barriers
  • Figure 32: Market Opportunities
  • Figure 33: PORTER'S Five Force Analysis